ConductScience.org, home

Paper1756534

Pharmacokinetics and biological activity in subcutaneous long-term administration of recombinant interferon-gamma in cancer patients.

Digel W and 3 others. Cancer Immunol Immunother, 1991. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Pharmacokinetics and biological activity in subcutaneous long-term administration of recombinant interferon-gamma in cancer patients. Papers, record 1756534. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1756534

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics and biological activity in subcutaneous long-term administration of recombinant interferon-gamma in cancer patients.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1991
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.28
iCite
Revised in PubMed
2024-04-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Digel WW
2Zahn GG
3Heinzel GG
4Porzsolt FF

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Interferon-gammaMajor topic
NeoplasmsMajor topic
Adolescent
Adult
Aged
Drug Administration Schedule
Female
Humans
Injections, Subcutaneous
Male
Middle Aged
Recombinant Proteins

Source PubMed

Download CSV of topics

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16159812Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma.Ann Intern Med1980https://conductscience.org/library/papers/6159812PubMed
26986204Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon.Cell Immunol1980https://conductscience.org/library/papers/6986204PubMed
33086433
The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
J Immunol1986https://conductscience.org/library/papers/3086433PubMed
46155160Towards tumor therapy with interferons, part II. Interferons: in vivo effects.Blood1980https://conductscience.org/library/papers/6155160PubMed
583651Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon.Proc Natl Acad Sci U S A1978https://conductscience.org/library/papers/83651PubMed
66173769Expression of human immune interferon cDNA in E. coli and monkey cells.Nature1982https://conductscience.org/library/papers/6173769PubMed
73899451Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy.Clin Pharmacokinet1985https://conductscience.org/library/papers/3899451PubMed
86192858Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia.Blood1983https://conductscience.org/library/papers/6192858PubMed
93131487The absence of interferon antibody formation in patients receiving recombinant human interferon-gamma.J Biol Response Mod1987https://conductscience.org/library/papers/3131487PubMed
104016788Recombinant alpha-2 interferon in the treatment of hairy cell leukemia.Cancer Treat Rep1985https://conductscience.org/library/papers/4016788PubMed
116175994Interferons: biochemical, cell growth inhibitory, and immunological effects.Prog Hematol1981https://conductscience.org/library/papers/6175994PubMed
126160587Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6160587PubMed
136411853Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.J Exp Med1983https://conductscience.org/library/papers/6411853PubMed
146336662Renal cell carcinoma: antitumor effects of leukocyte interferon.Cancer Res1983https://conductscience.org/library/papers/6336662PubMed
152439155Recombinant human TNF alpha stimulates production of granulocyte colony-stimulating factor.Blood1987https://conductscience.org/library/papers/2439155PubMed
163921249Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients.Cancer Res1985https://conductscience.org/library/papers/3921249PubMed
173091713A sensitive radioimmunoprecipitation assay for the detection of antibody to recombinant human gamma-interferon: comparison to a bioassay neutralization test.J Interferon Res1986https://conductscience.org/library/papers/3091713PubMed
186176159Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients.Ann Intern Med1982https://conductscience.org/library/papers/6176159PubMed
193088221Phase I study of multiple dose intramuscularly administered recombinant gamma interferon.J Clin Oncol1986https://conductscience.org/library/papers/3088221PubMed
203005410Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor.J Immunol1986https://conductscience.org/library/papers/3005410PubMed

See all 26 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1756534

GET https://conductscience.org/api/papers/v1/1756534/references?page=2